NEPH stock · TECH stock

NEPH vs TECH

Nephros Inc (NEPH) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.

Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.

Bio-Techne Corp (TECH) is a biotechnology company listed on US.

Latest reported NEPH revenue for 2024-12-31 was $14.2M. Net income was $74.0K. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.

Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

NEPH currently screens at market cap $40.9M and trailing P/E 48.3. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

Not investment advice. Open the NEPH and TECH stock pages for the full models.

Not investment advice.

Popular Stock Comparisons